MAGFORCE
LIVE

Serial Number

78474638

Owner

MAGFORCE AG

Attorney

Shauna M. Wertheim, Esq.

Filing Date

Aug 27, 2004

Add to watchlist:

No watchlists yet
View on USPTO

MAGFORCE Trademark

Serial Number: 78474638 • Registration: 3598491

MAGFORCE is a trademark filed by MAGFORCE AG on August 27, 2004. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MAGFORCE AG (3 trademarks)

MAX-PLANCK-STR. 3
12489 BERLIN , DE

Entity Type: 25

MagForce Nanotechnologies GmbH (3 trademarks)

Spandauer Damm 130
Berlin 14050 , DE

Entity Type: 99

Trademark Details

Filing Date

August 27, 2004

Registration Date

March 31, 2009

Published for Opposition

August 12, 2008

Goods & Services

Electronic scientific devices, namely,[ x-ray fluorescence spectrometer; nuclear magnetic resonance spectrometer;] devices for generating an alternating magnetic field;[ optical apparatuses, devices and instruments, namely, monochromators;] information processing equipments and apparatuses, namely, computer hardware; computer software for operating all of the aforementioned devices recorded on magnetic data carriers, CDs, magnetic tape carriers, [laboratory incubators for use in science]

Pharmaceuticals, pharmaceutical [and veterinary] products as well as compounds for healthcare, namely, anti-cancer preparations, preparations for the treatment of benign tumors[ preparations for the treatment or prophylaxis of arthritis, preparations for the treatment or prophylaxis of arthrosis, preparations for the treatment or prophylaxis of stenoses and restenoses, preparations for the treatment or prophylaxis of heart diseases, preparations for the treatment or prophylaxis of skin diseases]; pharmaceutical [and veterinary] products containing magnetic nanoparticles, namely, anti-cancer preparations, preparations for the treatment of benign tumors, [preparations for the treatment or prophylaxis of arthritis, preparations for the treatment or prophylaxis of arthrosis, preparations for the treatment or prophylaxis of stenoses and restenoses, preparations for the treatment or prophylaxis of heart diseases, preparations for the treatment or prophylaxis of skin diseases; contrast agents for medical use,] contrast agents for medical use containing magnetic nanoparticles; agents for diagnostic and medical purposes, namely, for imaging and detection of cancer, tumors,[ arthritis, arthrosis, stenosis, restenosis, heart diseases and skin diseases, ]agents for diagnostic and medical purposes containing magnetic nanoparticles;[ dietary supplements for medical purposes, baby food; medical plaster, dressing material for wounds and surgical use; teeth fillers and casting compounds for dental purposes, adhesives for dental plates, dental cement; deodorants, not for personal use, detergents for medical purposes, medical herb teas, ]chemicals for medical diagnostic use, namely, shift reagents, x-ray contrast agents, marker reagents for radio-spectroscopic and x-ray spectroscopic, UV-, IR-, NMR- and mass spectroscopic measurements

Chemicals for use in industry and science; magnetic nanoparticles, chemical particles having a nanometer size, chemicals and biopolymers containing nanoparticles for use in medical research and science; iron oxide based[ nanodots, nanoprobe, nano-sensing probe,] nanometals, nanoparticles for use in medical research and science; magnetites and maghemites for use in medical research and science

Medical devices and instruments containing magnetic nanoparticles, namely, medical implants, stents, catheters,[ catheter balloons,] implantable drug carrier, implants for sustained drug release, implants for chemo-embolization; medical devices and instruments coated with magnetic nanoparticles, namely, medical implants, stents, catheters, catheter balloons, implantable drug carrier, implants for sustained drug release, implants for chemo-embolization; systems with [magnets of high precision and appendant electronic instrumentations for nuclear magnetic resonance], medical technical devices, namely, hyperthermia devices and devices for local heating as well as components of afore mentioned devices for heating body tissue; hyperthermia systems for cancer treatment, namely, thermotherapy device comprising at least one coil for generating an alternating electromagnetic field; technical devices for stimulation of nanoparticles in an alternating magnetic field, namely, for heating body tissue, for activating pharmaceuticals attached to the nanoparticles, for release of pharmaceuticals attached to the nanoparticles;[ medical instruments and apparatuses, for breathing, namely, oxygen masks and oxygen monitors, anesthesia devices, incubators for medical use, shielding devices for actino-therapeutic, x-ray-, diagnostic-, computertomografic and medical facilities, especially shielding protection walls, radiation protection gates and radiation protection curtains]

Services for scientific and industrial research, provision of scientific literature for research, development and production; development services of nanoparticles, development services of medical devices and instruments coated with nanoparticles, development services of medical devices and instruments containing nanoparticles, development services of nanoproducts; development services referring to new medical devices and accessories for third parties; services for research and development medical devices and accessories; services for quality assurance of medical devices and accessories; analysis of magnetic and electromagnetic measurements for medical purposes, analysis of magnetic resonance tomographic measurements, creation of software for data processing, technical consulting services of third parties in the field of information and medical technology

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Feb 12, 2019 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Feb 12, 2019 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Feb 12, 2019 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 12, 2019 APRE
TEAS SECTION 8 & 9 RECEIVED
Jan 14, 2019 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Mar 31, 2018 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 11, 2015 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 11, 2015 C15A
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 8, 2015 ASCK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 1, 2015 APRE
TEAS SECTION 8 & 15 RECEIVED
Mar 23, 2015 E815
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 15, 2014 ASGN
REGISTERED-PRINCIPAL REGISTER
Mar 31, 2009 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Feb 24, 2009 ETOP
DATA MODIFICATION COMPLETED
Feb 9, 2009 DMCC
FAX RECEIVED
Jan 26, 2009 FAXX
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 10, 2008 ETOF
PUBLISHED FOR OPPOSITION
Aug 12, 2008 PUBO
NOTICE OF PUBLICATION
Jul 23, 2008 NPUB
EXAMINERS AMENDMENT MAILED
Jul 8, 2008 CNEA
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 7, 2008 PREV
ASSIGNED TO LIE
Jul 7, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 7, 2008 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 7, 2008 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jul 7, 2008 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 2, 2008 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 5, 2008 PBCR
ATTORNEY REVIEW COMPLETED
Apr 21, 2008 ATRV
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Mar 27, 2008 ATRQ
1(B) BASIS DELETED; NEW BASIS REQUESTED
Mar 27, 2008 ADBS
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Mar 25, 2008 PCBG
FAX RECEIVED
Mar 18, 2008 FAXX
ASSIGNED TO PETITION STAFF
Feb 19, 2008 APET
PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
Jan 22, 2008 PDCB
PAPER RECEIVED
Jan 22, 2008 MAIL
NOTICE OF ALLOWANCE CANCELLED
Jan 16, 2008 IUCN
SOU EXTENSION 1 GRANTED
Jul 16, 2007 EX1G
SOU EXTENSION 1 FILED
Jul 16, 2007 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 16, 2007 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 16, 2007 NOAM
PUBLISHED FOR OPPOSITION
Oct 24, 2006 PUBO
NOTICE OF PUBLICATION
Oct 4, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 6, 2006 PREV
ASSIGNED TO LIE
Sep 5, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 30, 2006 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 30, 2006 XAEC
EXAMINERS AMENDMENT E-MAILED
Aug 30, 2006 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 30, 2006 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 16, 2006 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 1, 2006 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 7, 2006 PREV
ASSIGNED TO LIE
May 12, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2006 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 20, 2006 TROA
CORRESPONDENCE E-MAILED
Oct 23, 2005 GRML
NON-FINAL ACTION WRITTEN
Oct 23, 2005 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2005 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 12, 2005 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 12, 2005 TROA
NON-FINAL ACTION E-MAILED
Mar 29, 2005 GNRT
NON-FINAL ACTION WRITTEN
Mar 29, 2005 CNRT
ASSIGNED TO EXAMINER
Mar 28, 2005 DOCK
NEW APPLICATION ENTERED
Sep 3, 2004 NWAP